Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Voriconazole - Pfizer

Next Previous
X
Search
Drug Profile

Voriconazole - Pfizer

Alternative Names: Betadex sulfobutyl ether sodium enabled IV voriconazole; Captisol-enabled IV voraconazole; SBECD enabled IV voriconazole; Sulphobutly ether beta cyclodextrin enabled IV voriconazole; UK-109496; Vfend

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Developer Ligand Pharmaceuticals; Pfizer
  • Class Antifungals; Fluorinated hydrocarbons; Pyrimidines; Small molecules; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Candidiasis; Fusariosis; Invasive bronchopulmonary aspergillosis; Mycoses

Most Recent Events

  • 02 Feb 2021 Launched for Mycoses in China (IV) before February 2021 (Ligand Pharmaceuticals pipeline, Feb 2021)
  • 02 Feb 2021 Launched for Mycoses in China (PO) before February 2021 (Ligand Pharmaceuticals pipeline, Feb 2021)
  • 07 Aug 2018 Registered for Mycoses in China (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top